Follow the ソレイジア・ファーマ株式会社 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ソレイジア・ファーマ株式会社 has logged 36 insider filings. Market capitalisation: €7.6bn. The latest transaction was reported on 16 January 2026 (Holding update). Among the most active insiders: Macquarie Bank Limited. Every trade is openly available.
36
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,509 of 28,169 companies
24.9
score / 100
Value
14
Quality
36
FCF yld-14%
Earn yld-11%
EV/EBITDA·
ROE-70%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Solexia Pharma Co., Ltd. is a company focused on the health and pharmaceutical sector, dedicated to developing innovative treatments. It is listed on the XTKS market.